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Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by
the rapid and progressive degeneration of upper and lower motor neurons in the spinal
cord, brain stem and motor cortex. The first gene linked to ALS was the gene encoding
the free radical scavenging enzyme superoxide dismutase-1 (SOD1) that currently has
over 180, mostly missense, ALS-associated mutations identified. SOD1-associated fALS
patients show remarkably broad mean survival times (<1 year to ∼17 years death
post-diagnosis) that are mutation dependent. A hallmark of SOD1-associated ALS
is the deposition of SOD1 into large insoluble aggregates in motor neurons. This is
thought to be a consequence of mutation induced structural destabilization and/or
oxidative damage leading to the misfolding and aggregation of SOD1 into a neurotoxic
species. Here we aim to understand the relationship between SOD1 variant toxicity,
structural stability, and aggregation propensity using a combination of cell culture and
purified protein assays. Cell based assays indicated that aggregation of SOD1 variants
correlate closely to cellular toxicity. However, the relationship between cellular toxicity
and disease severity was less clear. We next utilized mass spectrometry to interrogate
the structural consequences of metal loss and disulfide reduction on fALS-associated
SOD1 variant structure. All variants showed evidence of unfolded, intermediate, and
compact conformations, with SOD1G37R, SOD1G93A and SOD1V148G having the greatest
abundance of intermediate and unfolded SOD1. SOD1G37R was an informative outlier
as it had a high propensity to unfold and form oligomeric aggregates, but it did not
aggregate to the same extent as SOD1G93A and SOD1V148G in in vitro aggregation
assays. Furthermore, seeding the aggregation of DTT/EDTA-treated SOD1G37R with
preformed SOD1G93A fibrils elicited minimal aggregation response, suggesting that the
arginine substitution at position-37 blocks the templating of SOD1 onto preformed fibrils.
We propose that this difference may be explained by multiple strains of SOD1 aggregate
and this may also help explain the slow disease progression observed in patients with
SOD1G37R.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a disease characterized
by the progressive degeneration of both upper and lower motor
neurons, ultimately resulting in death. The symptoms of ALS
typically manifest in people aged 55–65 years, with younger
patients rarely being identified (Gordon, 2011). Post-diagnosis,
the average disease duration is approximately 3 years, although
patients suffering different familial variants can have shorter and
longer durations. Genetic studies of ALS patients have revealed
that 90% of cases are sporadic (sALS) and the remaining 10%
of cases are familial (fALS) (Renton et al., 2014). Several of the
fALS associated genes (TDP-43, C9orf72, FUS, ALS2) have roles
in the biogenesis and trafficking of RNA species, and another
clear grouping are associated with protein degradation (CCNF,
VCP, SQSTM1, UBQLN2, OPTN, TBK1); most are also linked to
frontotemporal dementia (Cirulli et al., 2015; Peters et al., 2015;
Williams et al., 2016). The first fALS linked gene discovered,
and most studied, is the gene encoding superoxide dismutase-
1 (SOD1) which is only associated with a pure motor neuron
disease phenotype.
Superoxide dismutase-1 (SOD1) is a cytosolic 32 kDa
homodimeric enzyme that catalyzes the dismutation of oxygen
radicals to either molecular oxygen or hydrogen peroxide
(McCord and Fridovich, 1969). Each subunit contains a
catalytically active copper ion, a zinc ion, and an intramolecular
disulfide bond. These post-translational modifications confer
substantial stability to the native fold of SOD1, endowing it
with resistance to heat denaturation and maintenance of catalytic
activity in denaturing conditions (Senoo et al., 1988; Rodriguez
et al., 2002). Zinc binding occurs spontaneously following
synthesis and folding, whereas copper binding and disulfide
bond formation are mediated by association with the copper-
chaperone for SOD1 (Rae et al., 2000; Furukawa et al., 2004).
Currently, there are known to be over 180 natural mutations
that can occur within the SOD1 sequence that are associated
with fALS [http://alsod.iop.kcl.ac.uk - (Abel et al., 2013)]. These
mutations occur throughout the SOD1 sequence, and it is
thought that all have the ability to destabilize the native fold,
leading to an increased propensity to misfold and/or aggregate
(Khare et al., 2006; Nordlund and Oliveberg, 2008; Byrstrom
et al., 2010; Munch and Bertolotti, 2010). Owing to the growing
evidence for prion-like propagation associated with SOD1 fALS
(Ayers et al., 2014, 2016; Grad et al., 2014; Zeineddine et al., 2015),
and the fact that a misfolded/aggregated wild-type SOD1 species
has been found associated with sALS (Bosco et al., 2010), it has
been suggested that there is a common pathogenic conformer or
aggregate species that exists for all SOD1 variants, although it is
yet to be elucidated.
Metal coordination and disulfide bond formation are
important for stability of SOD1 tertiary and quaternary structures
(Hayward et al., 2002; Tiwari and Hayward, 2003; Lynch et al.,
2004; Svensson et al., 2010), and their absence has been shown
to increase the aggregation propensity of SOD1 (Arnesano
et al., 2004; Ding and Dokholyan, 2008). From this, it has been
inferred that an immature/unfolded conformation(s) of SOD1
is responsible for aggregation. Investigation of these possible
unfolded SOD1 conformations has been difficult due to the
heterogeneity of non-native protein structures. High resolution
analyses, such as X-ray crystallography, are impeded by the
existence of disordered protein regions that can assume multiple
conformations (Banci et al., 2009), and typical separation
techniques, such as size exclusion chromatography (SEC) do not
provide sufficient resolution to separate different conformations
for downstream analysis (Hong et al., 2012), although use of
small-angle X-ray scattering coupled with SEC can provide
valuable insight into the structural plasticity of proteins in
solution by separating different conformers and oligomeric states
(Wright et al., 2011, 2016; Furukawa et al., 2015). Nuclear
magnetic resonance (NMR) spectroscopy has been used to great
extent on disordered SOD1, monitoring unfolding, refolding,
and even identifying a zinc-deficient form of SOD1 proposed as
a precursor to the toxic species (Luchinat et al., 2014; Szpryngiel
et al., 2015). Although NMR analysis is an extremely useful tool
in structural biology, it requires high concentrations of protein
(0.1−3mM), which can lead to undesirable artifacts, especially in
the case of protein-protein interactions.
In comparison, native mass spectrometry (MS) is a powerful
tool for the analysis of structurally heterogeneous protein
samples as it allows for the separation of different protein
species based upon mass, charge, and drift time when coupled
to ion mobility (IM-MS) (Mehmood et al., 2015), allowing for
the resolution of species in solution at variable concentrations.
This study details the use of native MS to investigate the
possible misfolded/unfolded conformations SOD1 can occupy
when metal binding and disulfide bonding are disrupted, and
the relationship of these species to SOD1 aggregation. We
first determined if there was a correlation between isolated
recombinant protein aggregation and cellular aggregation of
different SOD1 variants, focusing on SOD1-EGFP fusion
proteins. Next we attempted to assess the oligomeric state
of our SOD1 variants under similar aggregation conditions,
finding that SOD1 variants had differential mobility in both
SEC and native PAGE. This was followed by native MS
analysis to separate and analyse the variably destabilized
SOD1 species. Our observations indicate that the oligomeric
state of the SOD1 variants was primarily monomeric and
that the monomer assumed 3 conformations based upon
mass-to-charge distributions. The relative abundances of the
conformations were dependent upon the SOD1 variant being
analyzed and the formation of destabilized SOD1 monomer
correlated with cellular aggregation. Lastly, the slow progressing
SOD1G37R mutant had a high proportion of unfolded monomer,
high propensity to form oligomeric aggregates and insoluble
aggregates, but could not be seeded by G93A aggregates in a
plate-based aggregation assay, suggesting that it may exist in a
different strain to other aggregation prone mutants.
METHODOLOGY
Expression and Purification of
Recombinant SOD1
Plasmids encoding SOD1WT and SOD1G93A were a gift
from the Oliveberg group (Stockholm, Sweden). Plasmids
encoding SOD1G37R, SOD1H46R, SOD1D90A, and SOD1V148G
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were designed in-house and generated by Genscript (New Jersey,
USA). Protein expression and purification were performed
according to (Lindberg et al., 2002) with slight modifications.
Briefly, plasmids containing genes for the expression of SOD1
and yeast-CCS were transformed into chemically competent
BL21 (DE3) E. coli using heat-shock. Following transformation
expression cultures were induced using IPTG in the presence
of copper and zinc. Following lysis and ammonium-sulfate
precipitation, the expressed protein was purified using size
exclusion chromatography (Hiload 16/60 Superdex 75 PG, GE
USA) and anion exchange chromatography (HiTrap DEAE, GE
USA). Purity was assessed by SDS-PAGE and mass spectrometry,
with pure samples snap frozen and stored in 1 × PBS at −20◦C.
Misfolded/unfolded SOD1 was generated by incubating purified
SOD1 variants at a concentration of 30µM in 1 × PBS with
5mM EDTA and 20mM DTT at 37◦C for 2 h. All protein
concentrations were determined using a bicinchoninic acid assay.
Isolated Recombinant Protein Aggregation
Assays
Superoxide dismutase-1 (SOD1) variants were aggregated at a
concentration of 30µM (dimer) in 1 × PBS (pH 7.4) containing
20mMDTT, 5mM EDTA, with 10µM thioflavin T (ThT). Plate-
reader assays were performed on a POLARstar Omega (BMG
labtech) in clear bottomed 384-well plates (Greiner), with a final
well volume of 50µl. Following addition of DTT/EDTA to wells
containing SOD1 protein, the plate was incubated at 37◦C for
30min before being covered with an adhesive slip. Aggregation
was induced with double-orbital shaking at 300 rpm for 330 s
at the start of a 900 s cycle. ThT was excited at 440 nm and its
fluorescence was measured at 490 nm. Seeded aggregation assays
were carried out similarly, with the exception that the reaction
mixture was 30µM SOD1, 10mM DTT, 1 mM EDTA, 10µM
ThT, in 1 × PBS (pH 7.4). Seeded assays also contained 0.3%
(w/w) of total protein as seed from a previous aggregation assay.
Analysis of aggregation kinetics was carried out as described by
Cox et al. (2016).
Native Page Analysis
Superoxide dismutase-1 (SOD1) variants at a concentration of
30µM (10µg total protein per well) were loaded into stain-
free any kD gradient gels (Biorad, USA) in a tris-glycine buffer.
Gels were electrophoresed at 100V for 3 h at 4◦C with stirring.
Following electrophoresis, gels were imaged on a stain-free
imager (Biorad, USA).
Analytical Gel-Filtration and Buffer
Exchange
Analytical gel-filtration chromatography was carried out in
conjunction with buffer exchange of SOD1 variants into 200mM
NH4OAc (pH 6.8). SOD1 variants were concentrated using
microfuge concentrators (Vivaspin 25 10 kDa MWCO, GE
USA) to a concentration of ∼450µM prior to analytical gel
filtration. Concentrated native and DTT/EDTA-treated SOD1
variants were loaded onto either a Superdex-75 10/300 column
or Superdex-200 10/300 column (GE, USA) at a flow rate of
0.5 ml/min with the elution profile being measured at 280 nm,
and 0.5ml fractions being collected for immediate MS analysis.
Fractions were placed on ice as they eluted.
Mass Spectrometry
Mass spectrometry analysis was performed using a SYNAPT G1
HDMS (Waters, UK) with parameters set according to previous
work (McAlary et al., 2013). Briefly, SOD1 samples at 10µM
in 200mM NH4 OAc were loaded into gold-coated borosilicate
capillaries (made in-house) and subjected to nano-electrospray
ionization. All spectra were externally calibrated using 10mg/ml
caesium-iodide in 50% n-propanol, and were processed using
Masslynx 4.1. For determination of the abundances of the
observed conformations MATLAB R2014b (Version 8.4) was
used to fit Gaussians to the data.
Secondary Tissue Culture
Mouse neuroblastoma/motor neuron hybrid cells (NSC-34)
(Cashman et al., 1992) were cultured in Dulbecco’s modified
Eagles medium-F12 (DMEM-F12) (Invitrogen, Australia),
supplemented with 10% (v/v) heat inactivated fetal bovine
serum (FBS) (Bovogen Biologicals, Australia). In order to
passage and plate cells, they were washed once with DMEM-F12
and treated with 0.25% trypsin, 0.02% EDTA (Sigma-Aldrich,
Australia) to lift off the adherent cells. The cells were pelleted
via centrifugation (500 × g, 5 min) and resuspended in pre-
warmed DMEM-F12, supplemented with 10% FBS. Following
washing, plates and chamber-slides were seeded at a confluency
of 40% and cultured at 37◦C in a humidified incubator with 5%
atmospheric CO2 for 24 h prior to transfection.
Transfection of NSC-34 Cells
NSC-34 cells were transfected, 24 h post-plating into either
multi-well plates or chamber-slides (Ibidi Germany), using
Lipofectamine 3000 (Invitrogen, USA) according to the
manufacturer’s instructions. Lipofectamine 3000 reagent was
added to pre-warmed DMEM-F12 to a concentration of 6%
(v/v). P3000 reagent and plasmid DNA were added to a separate
DMEM-F12 volume to concentrations of 4% (v/v) and 20 ng/µL,
respectively. The DNA/lipofectamine complex was generated by
mixing one volume of 6% (v/v) lipofectamine in DMEM-F12,
with one volume of DNA/P3000 mix in DMEM-F12. The
DNA/lipofectamine mixture was incubated for 30min at room
temperature, after which it was dispensed onto cultured cells.
For cells that were co-transfected, the total amount of DNA was
halved between plasmid constructs.
Fluorescent Imaging
All cell imaging was performed using a Leica TCS SP5 Confocal
microscope (Leica, Germany). Cells were imaged live in 5%
atmospheric CO2, with the incubation unit set to a temperature
of 37◦C. For all confocal experiments, the argon laser power was
at 20%. All green-fluorescent protein (EGFP) tagged constructs
were excited with 10% laser power at 488 nm and emission was
analyzed from 507 to 550 nm. Images were acquired using a HCX
PL APO 63.0 × 1.20 water immersion objective, using PMT
detectors, with a pin-hole of 100µm.
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To quantify inclusion formation of SOD1-EGFP constructs, z-
stacks of transfected cells were acquired. Cells were cultured into
µSlide 8-well chamber slides (Ibidi, Germany) and transfected
with c-terminal SOD1-EGFP constructs. Imaging was performed
48 h post-transfection. Z-stacks series were acquired at 512× 512
pixels, laser scanning speed 400Hz, line and frame averaging =
1, where each image was a 400-500 nm slice of the z-axis. Each
Z-stack was systematically acquired in a new area of the well
to avoid overlap. At least five z-stack series were acquired per
well of a chamber slide, accounting for at least 100 transfected
cells imaged per well. Z-stacks were processed into a single
image using LAS-AF Lite software (Leica, Germany), where cells
containing inclusions were determined by the presence of bright
fluorescent puncta in the cytoplasmic region greater than 2µm
in diameter.
Time Resolved Fluorescent Imaging
To assess the toxicity of SOD1-EGFP constructs in NSC-34
cells over a time course, an IncuCyte R© automated fluorescent
microscope (Essen BioScience, USA) was used. NSC-34 cells were
plated into 12-wells plates at a confluency of 60% and were
transfected 24 h post-plating. Cells were dissociated 24 h post-
transfection and plated into 96-well plates at a confluency of 20%
in phenol-red-free DMEM-F12 supplemented with 10% FBS. At
least 3 images were acquired per-well at 2 h time points for 68 h in
both phase and green channels with the green channel acquisition
time at 400ms. The processing definition generated to analyse
the images utilized top-hat back ground subtraction [radius =
100µm, threshold = 0.5 general calibration units (GCU)], edge-
splitting (edge sensitivity= 0), filters (minimum area= 175µm2,
minimum mean intensity = 1.2). The equations below describe
data analysis and presentation.
First, the number of GFP positive cells at each time point
(GFPtx) for each transfection was normalized to the intial value
(GFPt0) determined in the first scan after plating.
GFPtx
GFPt0
= NormalisedGFPtx
Then, the normalized values of the SOD1 mutants at each
time point (Normalised GFPtx) were divided by the normalized
SOD1WT data at the same time points to determine the
proportion of GFP positive cells relative to SOD1WT .
NormalisedGFPtx
SOD1WTGFPtx
= SOD1mutantGFPrelativetoSOD1WT
FloIT Assay by Flow Cytometry
The FloIT assay was performed as described in (Whiten et al.,
2016). Briefly, NSC-34 cells were transiently transfected in a
24-well plate with SOD1-EGFP constructs as described above.
Cell were harvested, washed twice and resuspended in 1 ×
PBS (0.5mL/tube). A 150µL aliquot was taken and used to
analyse transfection efficiency. The remaining cells were pelleted
(300 × g, 5min) and placed on ice. Supernatant was removed
from each sample and the cells were lysed with the addition
of 0.5% Triton X-100 in 1 × PBS containing a 1:1000 dilution
of RedDot2 immediately prior to flow cytometric analysis.
Events were analyzed using a LSRFortessa X-20 Cell Analyzer
(BD Biosciences) with the excitation set to 488 nm and the
emission collected with a 525/50 band-pass filter for EGFP, and
an excitation of 640 nm with the emission collected using a
670/30 nm band-pass filter for RedDot2. All parameters were
set to log10 during acquisition from cell lysates, which were
gated according to forward and side scatter. The forward scatter
threshold was set to the minimum value (200 AU) to minimize
the exclusion of small protein inclusions. Nuclei were identified
based on RedDot2 fluorescence and forward scatter for removal
from further analysis. The remaining particles were analyzed
for presence of inclusions based on EGFP fluorescence, forward
scatter, and comparison to lysates of NSC-34 cells expressing
EGFP only. The number of inclusions in the population of
particles was normalized to the number of nuclei, and reported as
inclusions/100 transfected cells (iFloIT) according to the equation
iFloIT = 100
(
ni
γ .nnuc
)
where ni represents the number of inclusions acquired, nnuc is
the number of nuclei acquired, and γ is the transfection efficiency
(expressed as a fraction).
RESULTS
Cellular Aggregation Correlates with Cell
Loss
It has been previously shown that SOD1 variants expressed in
cultured cells have different propensities to aggregate (Turner
et al., 2005; Prudencio et al., 2009). This variation in aggregation
may offer an explanation to the large disparity in average
length of disease duration between SOD1 mutations. We first
sought to determine the aggregation propensities of our chosen
SOD1 variants as EGFP fusion proteins in cultured cells
using microscopy. To this end, mouse neuroblastoma/motor
neuron hybrid cells (NSC-34) (Cashman et al., 1992) were
transfected with SOD1-EGFP constructs and imaged 48 h post-
transfection and the number of transfected cells that formed
inclusions counted. We chose to work with variants SOD1WT,
SOD1G37R, SOD1H46R, SOD1D90A, SOD1G93A, and SOD1V148G
owing to their variable patient survival time (SOD1G37R =
∼17, SOD1H46R = ∼17.6, SOD1D90A ∼8, SOD1G93A ∼3.1,
SOD1V148G = ∼2.1 years) (Wang et al., 2008). We observed
that variants, SOD1G37R, SOD1G93A, and SOD1V148G had
significantly increased populations of transfected cells containing
inclusions when compared to SOD1WT (Figures 1A,B). In
contrast, there was no significant difference between SOD1WT
and the variants SOD1H46R and SOD1D90A (Figure 1B). The
flow cytometry based FloIT assay showed results similar to
manual counting (Figure 1C). While the FloIT technique finds
2–3 times more inclusions per 100 cells, this is due to the
fact that multiple inclusions can occur in a single cell (Whiten
et al., 2016). Regardless, the outcome from manual counting
and FloIT analysis demonstrate that SOD1G37R, SOD1G93A, and
SOD1V148G aggregate significantly more in cells that the other
variants tested. We next examined the effects of overexpression
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FIGURE 1 | SOD1 variants have differential aggregation propensities in NSC-34 cells. NSC-34 cells were transiently transfected with SOD1-EGFP constructs
and imaged 48 h following transfection to examine the formation of inclusions. (A) Representative images of NSC-34 cells transfected with different SOD1-EGFP
variants with arrows marking cells with inclusions. Scale bar represents 50µM. (B) Manual counting of inclusions from imaged cells showed that SOD1variants had
differential aggregation propensities when expressed in NSC-34 cells. (C) FloIT analysis of transfected NSC-34 cells. Cells were lysed and the inclusions counted
using flow cytometry 48 h post-transfection. (D) The toxicity of SOD1-EGFP constructs compared to SOD1WT in NSC-34 cells. (E) Cell death is plotted against
cellular aggregation propensity, there is a plausible correlation between aggregate load and cell death at 48 h post-transfection. Statistical significance was determined
via a one-way ANOVA with a Tukey’s multiple comparison post-test (***P < 0.001, **P < 0.01, ns = non-significant).
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of SOD1-EGFP constructs on cell survival through time using
real-time imaging. The number of surviving cells was followed
and plotted relative to SOD1WT survival (Figure 1D). As
previously observed (Turner et al., 2005), the survival of cells
expressing SOD1 variants correlated with the number of cells
with aggregates (Figure 1E). That is the variants SOD1G37R,
SOD1G93A, and SOD1V148G had significant levels of cell death,
while SOD1H46R had an intermediate level of cell death and
SOD1D90A was no different to SOD1WT. This suggests that the
cellular aggregation propensity of the variant predicts cell death
in NSC-34 cells.
Aggregation Propensity of Recombinant
SOD1 Does Not Always Predict Its Cellular
Aggregation
The variation in cellular aggregation propensity between SOD1
variants could be due to their intrinsic propensity to aggregate, or
given that cells actively generate inclusions in a manner thought
to represent a quality control compartment (Weisberg et al., 2012;
Farrawell et al., 2015), the level of aggregation may represent an
ability of a particular variant to evade cellular protein quality
control machinery (Yerbury et al., 2013, 2016). To distinguish
between these two possibilities, we sought to assess if there was
a correlation between aggregation of purified recombinant SOD1
and SOD1-GFP aggregation in cells. Aggregation of recombinant
SOD1 was performed as previously described by us and others
(Furukawa et al., 2008; Roberts et al., 2013; Yerbury et al., 2013),
making use of DTT (to reduce the intramolecular disulfide)
and EDTA (to chelate Cu and Zn), as well as shaking, to
promote aggregation of the SOD1 variants. Aggregation was
measured via Thioflavin T fluorescence, which has been used
as a measure of amyloid formation and is thought to fluoresce
when it binds to the β-sheet structure characteristic of amyloid.
The aggregation propensities differed between SOD1 variants
(Figures 2A,B), with SOD1V148G, SOD1G93A, SOD1G37R, and
SOD1D90A obeying Boltzmann-sigmoidal kinetics typical of
fibrillar aggregation. SOD1 aggregation is noted to be a highly
stochastic process, with large variance between technical and
biological replicates (Abdolvahabi et al., 2016); however, a
comparison of the rates of fibril elongation (measured as change
in ThT fluorescence; Figure 2C) between two assays here showed
that inter-assay variation was minimal with the exception of
SOD1G93A. SOD1WT, and SOD1H46R did not fit standard fibrillar
aggregation kinetics, and as such analysis of the fibril elongation
phase was not performed on these variants. Rather, SOD1WT
and SOD1H46R did not seem to aggregate at all under our
assay conditions (20mM DTT, 5mM EDTA 1 × PBS 37◦C,
shaking agitation) or was not aggregating into fibrils. For the
most part, our assays suggested that propensity to aggregate was
dependent upon mutation, and when we plotted the relative
final fluorescence of each SOD1 variant in the first isolated
aggregation assay (Figure 2A) against the inclusion formation
data from transfected mammalian cells (Figure 2D) we observed
a relatively weak correlation (r2 = 0.6). However, if we omit
SOD1G37R as an outlier, due to its interestingly high propensity to
form inclusions in cells comparative to its patient survival time,
FIGURE 2 | Isolated recombinant SOD1 aggregation. Aggregation of
purified recombinant SOD1 as promoted with 20mM DTT 5mM EDTA in 1 ×
PBS, with shaking at 37◦C, and was monitored by ThT fluorescence. (A,B)
Plate-based aggregation assay of recombinant SOD1 variants showing the
differential aggregation profiles of each variant where each panel represents a
separate assay under the same conditions. Dotted lines represent SEM of 4
technical replicates. (C) Analysis of the fibril elongation rate (measured as
1ThT fluorescence) of assays (A,B). SOD1WT and SOD1H46R are not
included due to the sigmoidal fit being below r2 = 0.75. (D) Plotting the
percentage of cells with inclusions against the relative maximum ThT signal
from assay A gave an r2 value of 0.60 (solid black line) which was
strengthened to 0.86 (dotted line) when SOD1G37R was omitted from analysis.
the correlation is much stronger (r2 = 0.86). These data taken
together suggest that in our case, with the exception of SOD1G37R,
aggregation propensity of isolated SOD1 can predict its cellular
aggregation.
DTT and EDTA Cause Changes in SOD1
Oligomeric State
A proposed common characteristic of SOD1 variants is dimer
destabilization and dissociation into monomers, which can
subsequently lead to the formation of higher order aggregates
in vitro (Nordlund and Oliveberg, 2008). Indeed, antibodies
detecting epitopes exposed only in the misfolded SOD1
monomer show immunoreactivity in motor neurons from
human tissue as well as transgenic rat and mouse (SOD1A4V,
SOD1G93A, and SOD1G37R) models of disease (Rakhit et al.,
2007). To determine if propensity to dissociate to monomer was
related to cellular aggregation we used the same destabilizing
conditions used above (30µM SOD1 20mM DTT, 5mM
EDTA in 1 × PBS) but examined oligomeric state after
2 h (i.e., prior to insoluble aggregates being formed). Native
PAGE of our variants at a concentration of 15µM resolved
SOD1WT, SOD1H46R, and SOD1D90A into clear monomer
Frontiers in Neuroscience | www.frontiersin.org 6 November 2016 | Volume 10 | Article 499
McAlary et al. SOD1 Misfolding Predicts Cellular Aggregation
and dimer populations (Figure 3). Interestingly, we observed
no separate monomer or dimer populations for SOD1G37R,
SOD1G93A, or SOD1V148G. Rather, the bands seem to indicate
that a large proportion of the protein remained dimeric under
aggregation inducing conditons. In particular, SOD1G37R showed
a substantial difference compared to SOD1WT as there was a large
proportion of protein that had a lower mobility when compared
to the dimer band, suggesting the presence of larger oligomeric
species. Native PAGE has been used previously to investigate
the electrophoretic mobility of SOD1 variants following disulfide
reduction (Tiwari and Hayward, 2003), where it was proposed
that increased mobility was most likely a result of metal loss, and
retarded mobility was most likely a result of a conformational
change in the protein structure.We next used analytical SEC after
incubation in DTT and EDTA, in order to further investigate
oligomeric distribution. We observed that the elution profiles of
the SOD1 variants corresponded closely to the mobility observed
for each variant in the native PAGE assay (Figure 3), suggesting
similar changes were detected by each technique. The dimer
FIGURE 3 | Analytical size-exclusion chromatography of SOD1
variants. SOD1 variants were incubated at 37◦C, in 1 × PBS, with 20mM
DTT, and 5mM EDTA, for 2 h. After incubation, samples were concentrated at
4◦C to 450µM in a volume of 100µl and loaded onto an analytical S-75
column equilibrated in 200mM NH4OAc, and eluted at 0.5ml/min into 0.5ml
fractions. Black is control native SOD1 which was not incubated in the
presence of DTT or EDTA. Blue is SOD1 + DTT + EDTA, which showed
different elution profiles for all SOD1 variants, with peaks at ∼12 mL being
labeled “a” and the peak at ∼14mL being labeled “b.” Inset above each
chromatogram is native PAGE of the 2 h incubation time point.
and monomer populations were, again, apparent for SOD1WT,
SOD1H46R, and SOD1D90A, with the dimer eluting at ∼12.5mL,
and the monomer at ∼14.3mL. However, the elution profile of
the DTT/EDTA-treated SOD1 dimer was distinct to the primarily
dimeric non-treated controls (∼13.6mL), indicating a change in
the hydrodynamic volume of the SOD1 dimer. This shift to a
lower elution volume was observed for all SOD1 variants, with
SOD1G37R, SOD1G93A, and SOD1V148G having major elution
peaks at ∼12.5ml, but no peak at ∼14.3mL in contrast to
SOD1WT, indicating a lack of monomer. Interestingly, SOD1G37R
showed substantial protein at the void volume indicating the
presence of oligomeric species with masses greater than or equal
to ∼100 kDa (S-75 10/300GL column). SOD1G93A, SOD1V148G,
and to a lesser extent SOD1D90A showed the presence of
oligomeric species with peak shoulders ranging from ∼9 to
11mL. The analytical SEC, in conjunction with the native PAGE
analysis, suggest that after a 2 h treatment with DTT and
EDTA, SOD1 undergoes a conformational change that affects
the hydrodynamic volume and the packing of the protein. It is
well known that changes to the structure of molecules can make
SEC data ambiguous (Hong et al., 2012), potentially making the
interpretation of these data complicated. Due to this, native mass
spectrometry analysis was performed on fractions eluted from
analytical SEC assays.
Putative SOD1 Dimer from SEC Is Unfolded
Monomer
The native PAGE and analytical SEC data indicated the variable
presence of SOD1 dimer and monomer populations depending
on the variant. In addition, a potential change in dimer
conformation was observed as the dimer peak had a lower elution
volume after treatment. Native mass spectrometry (MS) can be
used to simultaneously investigate the suite of potential species
in this dynamic system, giving high-resolution mass data that
can also be used to determine modification states (disulfide
status, metal binding, oxidative modification). MS was used to
analyse the main peaks eluting from the analytical SEC from
Figure 3 (MS analysis in Figure 4), finding that in the case
of SOD1WT, (Figures 4A,B) the oligomeric distribution in the
mass spectra matched the oligomeric state determined from the
SEC (i.e., the peak at 12.5mL was predominantly dimer and
the peak at 14.3mL predominantly monomer). The charge state
distributions of both monomer and dimer in this assay were
similar to that observed previously for native SOD1 variants
(dimer 9 – 12+, monomer 7 – 8+) (McAlary et al., 2013).
Analytical SEC of SOD1G93A resulted in only one major peak
from DTT/EDTA treatment at 12.5 mL (peak a), consistent
with the elution of the DTT/EDTA-treated SOD1WT dimer peak
(Figure 3). However, when this was analyzed via MS, it was
observed that a substantially higher abundance of monomer
ranging from charge states 7+ to 21+ was present (Figure 4C).
This broad monomeric charge state distribution was also
observed in the ∼12mL peak for SOD1G37R (Figure 4D, peak
a), the ∼14.2 mL peak for SOD1D90A (Supplementary Figure
1A), and the ∼12.1mL peak for SOD1V148G (Supplementary
Figure 1B), although each variant comprised different relative
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FIGURE 4 | Native mass spectrometry of peaks from analytical SEC. Fractions from under peak apexes of DTT/EDTA-treated SOD1 were subject to mass
spectrometry under gentle conditions optimized to maintain a “solution-like” conformation. Oligomeric and conformational state is represented by ellipsoids and lines
above peaks with charge states marked. (A) Spectra of peak “a” from SOD1WT showing a primarily dimeric conformation similar to what is observed in native SOD1
(McAlary et al., 2013). (B) Spectra of peak ‘b’ from SOD1WT showing a primarily monomeric conformation at charge states similar to native monomeric SOD1WT
(McAlary et al., 2013). (C) Spectra of peak “a” from SOD1G93A showing a primarily monomeric distribution with peaks corresponding to monomeric SOD1 with
substantially higher charge states than what was observed in SOD1WT. (D) Spectra of peak′a′ from SOD1G37R showing a similar oligomeric and conformational
distribution to SOD1G93A with greater abundance of highly charged (9–21+) monomer.
abundances of the highly charged monomer ions (9 – 21+).
The charge state distribution of proteins in mass spectrometry is
dependent upon conformation (Prakash and Mazumdar, 2005),
and the presence of these highly charged monomeric ions is
indicative of a variably unfolded protein in the solution phase,
due to greater access of solvent to chargeable sites during
ionization. SOD1 contains 23 basic amino acids (His = 8, Lys
= 11, Arg = 4), and when recombinantly expressed and purified
from E. coli, is methionine cleaved but not acetylated at its N-
terminus (Leinweber et al., 2004), meaning it can theoretically
carry 23 positive charges if fully unfolded. Our data shows a
maximum of 21 charges applied to SOD1G93A (Figure 4), and
even in the case of SOD1G37R (Figure 4), which has 24 chargeable
sites, we only observed a maximum of 21 charges, suggesting
that 2 (3 for SOD1G37R) of the basic amino acids are masked
from protonation. Taken together we conclude that themonomer
ions ranging from 7 to 11+ have maintained some structure after
DTT/EDTA treatment, and that 12 – 21+ ions are representative
of a highly unfolded monomer.
SOD1G37R Has a High Propensity to Form
Oligomeric Aggregates
The elution profile of SOD1G37R, from analytical SEC, showed
a large abundance of protein in the void volume, indicating
high molecular weight oligomeric species. In order to identify
oligomeric species mass spectrometry was performed on the void
volume fraction as well as a second analytical size exclusion
analysis with freshly prepared DTT/EDTA treated SOD1G37R
using an S-200 column (1.3MDa exclusion limit). The S-200
SEC of SOD1G37R (Figure 5A) showed a primary elution peak
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for DTT/EDTA treated SOD1G37R at ∼15.6mL compared to the
untreated control SOD1G37R at ∼16.5mL. This lower elution
volume was consistent with the peaks observed in the S-75 SEC
(Figure 3). The absorbance at 280 nm was broad ranging from 8
to 21mL, with 8–14mL corresponding to high molecular weight
species, and 18–21mL likely corresponding to residual DTT from
the treatment (MS of this peak showed no protein signal–data
not shown). To identify the main oligomeric species of the major
peak (Figure 5A, peak a), mass spectrometry was performed
on this fraction (Figure 5B), which showed the charge state
distribution, of primarily monomeric SOD1G37R, similar to that
FIGURE 5 | Analysis of the void volume peak from DTT/EDTA-treated
SOD1G37R. Owing to the observation that a large portion of SOD1G37R
eluted in the void volume, this fraction was analyzed with native MS. (A) S-200
column chromatogram of native SOD1G37R (black) and DTT/EDTA-treated
SOD1G37R (blue) showing differences in elution profile where
DTT/EDTA-treated is eluting at lower volumes showing a broad oligomeric
distribution. The main peak is labeled “a” and markers above the
chromatogram represent molecular weight standards. (B) Spectra of peak “a”
from the S-200 chromatogram showing a similar distribution of SOD1G37R to
that seen previously in the S-75 column analysis. (C) Spectra of the void
volume peak from the SOD1G37R S-75 column analysis showing a broad
oligomeric distribution of SOD1G37R ranging from 1 to 12 subunits. (D)
Theoretical spectra and deconvolution of the mass spectra observed in (C),
showing where peak overlap may occur between oligomers, as well as the
major charge state of each oligomer. (E) Graphing the relative abundance of
each oligomer shows a pattern whereby oligomers are formed as groups of 4
subunits due to the relatively low abundance of 2–3 and 5–7 mers and no
9–11 mers. (F) Plotting the average charge of each oligomer against the
number of subunits in that oligomer gives are strong r2 value of 0.99, indicating
that the association of these oligomers proceeds in a ordered fashion.
observed from the S-75 SEC (Figure 4). The fractions at lower
elution volumes, containing oligomeric SOD1G37R, were also
subject to MS, however low signal was acquired, most likely due
to the very low abundance of the oligomers present. To overcome
this, the void volume fraction of the SOD1G37R S-75 SEC analysis
was subject toMS.We observed a broad distribution of oligomers
ranging from 1 to 12 subunits (Figure 5C), with the monomer
being the most abundant species, indicating that the oligomers
eluted from the column were highly labile. Generation of a
theoretical mass spectrum containing the potentially identified
species allowed for the correct assignment of each ion species
(Figure 5D). We plotted the abundance of each oligomer to
determine if there was a pattern of oligomerization, and found
that the large oligomers were assembling in patterns of 4 subunits,
as shown by the abundance of oligomers composed of 4, 8,
and 12 subunits, and the absence of oligomers made from 7, 9,
10, or 11 subunits (Figure 5E). Since the monomer and dimer
ions detected from this fraction were showing a charge state
distribution typical for SOD1 (monomer = 7−8+, dimer = 9–
12+), we plotted the average charge of each oligomeric state
against the number of subunits in that oligomer, and found that
the charge added per subunit addition was consistent at ∼2
charges per subunit added to the complex, indicating that the
oligomers were forming in an ordered fashion (Figure 5F).
Destabilised Monomer Abundance
Predicts Cellular Aggregation
Given the identification of various states of unfolded monomer
from SEC peaks we next wanted to perform a direct comparison
of the relative abundances of charge states, and oligomeric
distributions for each variant. This was achieved by analyzing
the total protein content of each experiment to allow for
comparison. Here we observed, that for each SOD1 variant after
DTT and EDTA treatment the major species was monomeric,
ranging from charges of 7+ to 21+ (Figure 6), as previously
observed (Figures 4, 5). The dimer abundance was substantially
decreased in all cases, compared to previous spectra that were
acquired from peak a in analytical SEC. This indicates that
the pooling and dilution of the samples from analytical SEC
resulted in dissociation of the dimer. In the case of SOD1G37R
(Figure 6B), there was no evidence of any oligomeric species,
even though fractions thought to contain them were included
into the pooled sample. This is most likely due to a combination
of the biases involved in mass spectrometry based analyses,
such as this, where system parameters determine sensitivity at
specific mass ranges, and the previously observed labile nature
of the oligomers. In contrast to previously acquired spectra
from fractions corresponding to peaks in the analytical SEC
(Figures 4, 5), it was observed that highly charged monomer was
present for all SOD1 variants, although at different abundances
for each SOD1 variant. SODWT, SOD1H46R, and SOD1D90A
(Figures 6A,C,D, respectively) showed relatively low abundances
of highly charged SOD1 monomer, instead the major ion species
was the monomeric 8+ charge state. SOD1G37R, SOD1G93A,
and SOD1V148G (Figures 6B,E,F, respectively) had considerably
increased relative abundances of highly charged monomeric
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FIGURE 6 | Mass spectra of pooled DTT/EDTA-treated SOD1 variants from SEC. Fractions across the elution profile containing SOD1 were pooled, diluted to
a concentration of 10µM, and subject to mass spectrometry. (A) SOD1WT showing a high abundance of monomer (gray) compared to dimer (black). Inset is an
expansion of the high charged 10 – 21+ monomer ions, normalized to the 10+ ion intensity. (B) SOD1G37R spectrum showing that highly charged monomer is the
major species present. (C) SOD1H46R showing a primarily low charged monomeric distribution. Inset is an expansion of the high charge region normalized to the 9+
ion intensity. (D) SOD1D90A showing that the most abundant ion species is the 8+ charge state with low abundance of highly charged monomer. Inset is an
expansion of the high charged region, normalized to the intensity of the 16+ ion. (E) SOD1G93A showing a substantial abundance of high charged monomer. (F)
SOD1V148G showing a substantial abundance of high charged monomer.
species, in comparison to the typical 7+ and 8+ monomeric
charge states.
Following the analysis and identification of protein species
evident from a close inspection of different monomer ions,
it was determined that there were three main monomeric
conformations that were being detected by MS. These
conformations were termed compact, intermediate, and
unfolded due to the major species across the monomeric ions
being reduced apo-SOD1 for all variants i.e., no holo-SOD1
was observed. It was also based on the Gaussian distribution of
peaks (Figure 7A) where we determined the relative abundance
of each peak and plotted the abundance of each charge state.
From these Gaussian fits it was possible to determine the
relative abundance of each conformation for all SOD1 variants
(Figure 7B).We found that SOD1WT, SOD1H46R, and SOD1D90A
monomers primarily inhabited the compact conformation,
with much lower abundances of intermediate and unfolded
conformations. SOD1G37R, SOD1G93A, and SOD1V148G had far
higher abundances of intermediate and unfolded monomer,
compared to SOD1WT, and out of the three variants, only
SOD1G37R showed a higher abundance of unfolded monomer
compared to compact monomer. Since SOD1 aggregation has
been previously proposed to be dependent upon the amount of
unfolded/destabilized protein (Byrstrom et al., 2010), the relative
ThT intensity from previous aggregation data (Figure 2A) was
plotted against the percentage of monomer that was destabilzed
(sum of intermediate and unfolded abundances) (Figure 7C).
The correlation was relatively weak (r2 = 0.31), however when
SOD1G37R was omitted from the linear fit, the correlation
became much stronger (r2 = 0.70). SOD1G37R is a curious outlier
as it is defined as “wild-type like” due to its structural similarities
with SOD1WT (Hart et al., 1998) and has a long variable disease
duration of ∼17 years (Wang et al., 2008), yet in our assays
presents severe structural destabilization on similar levels as
the aggressive SOD1G93A and SOD1V148G variants (∼2.2 and
∼2.3 years patient survival, respectively). Given that aggregation
propensity did not very well predict cellular aggregation we next
asked whether the relative abundance of destabilized monomer
correlated with cellular aggregation (Figure 7D). Here the
correlation was very strong (r2 = 0.87) and as such it seems that
the main predictor of cellular aggregation is the propensity of the
SOD1 variants to unfold as previously suggested (Nordlund and
Oliveberg, 2008).
Unfolded SOD1G37R Does Not Template on
to SOD1G93A Seeds
While we observe a strong correlation between propensity to
unfold, cellular aggregation and resultant cell loss, translating
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FIGURE 7 | Determination of the abundance of monomeric
conformations detected by mass spectrometry. (A) Plotting the
abundance of each charge state allowed for the determination of 3 Gaussian
distributions that correspond to increasing charge states and decreasing peak
width, indicative of 3 conformations (compact = blue, intermediate = green,
unfolded = red). (B) The abundance of each specific conformation for each
SOD1 variant shows the monomeric distribution where SOD1WT, SOD1H46R,
and SOD1D90A present a primarily compact monomeric distribution,
compared to the other variants which showed high abundances of
intermediate and unfolded monomer conformations. Error bars represent SD
of the mean from 3 separate DTT/EDTA treatments of 3 separate
nano-electrosprays. (C) Plotting the percentage abundance of destabilized
monomer (unfolded and intermediate conformation) against the relative ThT
intensity from aggregation assay A (Figure 2) showed a weak correlation (r2 =
0.31), however omission of SOD1G37R from the linear fit gave a much stronger
correlation (r2 = 0.70). (D) Plotting the percentage abundance of destabilized
monomer against the percentage of cells containing inclusions after
transfection showed a strong correlation (r2 = 0.87). Error bars represent SD
of the mean from at least 3 separate experiments.
this to human disease severity is limited by the fact that one
of our variants SOD1G37R has a high propensity to aggregate
and is toxic in cells but has a long mean disease duration
of 17 years. The concepts of aggregate strains and prion-like
seeding have recently become prominent within the study of
neurodegenerative disease, especially relating to ALS (Grad et al.,
2014; Bergh et al., 2015; Lang et al., 2015; Bidhendi et al., 2016).
Owing to the fact that spinal cord material from SOD1G37R
mice were unable to propagate disease in SOD1G85R mice while
SOD1G93A material was (Ayers et al., 2014), we next performed
an experiment to elucidate if this unfolded species could
template onto other preformed SOD1 aggregates. SOD1G93A was
chosen to be the ‘seed’ variant, as we had previously shown
it could seed SOD1WT aggregation (Grad et al., 2014), in this
experiment a minimal amount of preformed aggregate seed
(seed was 0.3% total protein by mass) was added to the assay.
Remarkably, it was observed that SOD1G37R did not respond to
the addition of seed, whereas SOD1WT showed an appreciable
response (Figures 8B,D) and SOD1G93A showed significantly
altered aggregation kinetics (Figures 8A,D). SOD1G37R showed
no difference in either fibril elongation rate (measured as change
in ThT fluorescence) (Figures 8C,D), or lag phase (Figure 8D),
indicating that the addition of the seed was not affecting either
the nucleation time, or the generation of fibrillar structures. The
kinetics of SOD1WT were difficult to determine due to a weak
sigmoidal fit, however it was clear from the assay (Figure 8A) that
the addition of SOD1G93A seed increased aggregation. Addition
of seed to SOD1G93A aggregation significantly increased the
elongation rate (Figure 8D) compared to no seed, and also
significantly decreased the lag phase (Figure 8E), indicating that
the addition of seed was pushing the aggregation reaction toward
fibril elongation, overcoming the need to form aggregate nuclei.
Next we compared the fold increase in the mean maximum
ThT fluorescence between variants (Figure 8F) after seeding
and found that SOD1G37R had only a slight increase in max
fluorescence, compared to SOD1WT which was higher than
SOD1G37R and SOD1G93A which was substantially higher than
both other variants. Taken together, this work suggests that
SOD1G37R may be aggregating as a different strain that is
dependent upon the substitution of arginine at position-37.
DISCUSSION
In this work we have shown that the reduction and chelation of
SOD1 variants induces unfolding into multiple conformational
states, and that the major predictor for cellular aggregation of
SOD1 variants is the abundance of destabilized SOD1 states.
It is well known that disruption of the metal ions and the
intramolecular disulfide has severe effects upon SOD1 structural
stability (Hayward et al., 2002; Tiwari and Hayward, 2003; Lynch
et al., 2004; Banci et al., 2009; Svensson et al., 2010). Indeed, in the
native conformation (metal bound, disulfide bonded form) most
ALS-associated SOD1 variants have high melting temperatures,
however, when reduced and metal-free, some variants, such
as SOD1G93A, melt below physiological temperature (Furukawa
and O’Halloran, 2005; Rodriguez et al., 2005). Taking this into
account, it is clear that the conformational distribution we
observed in MS assays is a result of the lower thermal stabilities
of the SOD1 variants when in their reduced apo-form, which
was induced via incubation in DTT and EDTA at physiological
temperature. Take SOD1G93A for example, which in its reduced
apo-form, has a reported melting temperature of 31.2 ± 0.3◦C
(Furukawa and O’Halloran, 2005). We observed that SOD1G93A
was significantly destabilized following DTT/EDTA treatment at
physiological temperature, in agreement with this previous work.
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FIGURE 8 | SOD1G37R is resistant to seeding by preformed SOD1G93A aggregates. Aggregation of SOD1 was promoted with DTT, EDTA, and shaking, with
the formation of fibrillar structures being monitored by ThT fluorescence. Preformed SOD1G93A aggregates were added (or not) at a final amount of 0.3% total protein.
(A) Aggregation assay of SOD1G93A normalized to the maximum signal showing the ThT fluorescence over time for each sample. Dotted lines represent the
maximum fluorescence of SOD1WT (red) and SOD1G37R (blue) assays shown in panels B and C, respectively. (B) Aggregation assay of SOD1WT with and without
seed, normalized to the maximum fluorescent signal. (C) Aggregation assay of SOD1G37R with and without seed, normalized to the maximum fluorescence signal (D)
Kinetic analysis gave the fibril elongation rate (measured as change in ThT fluorescence), showing that seeded SOD1G93A had a significantly increased fibril elongation
rate compared to other treatments. SOD1WT is not shown here due to it not aggregating without seed. (E) Kinetic analysis gave the lag phase of aggregation,
showing that addition of seed significantly decreased the lag phase of SOD1G93A but not SOD1G37R. (F) Comparing the fold increase in the max fluorescence (Fmax)
values when aggregation was seeded for each variant, showing that SOD1G93A and SOD1WT had greater increases compared to SOD1G37R. Each assay presented
here is representative of 2 separate assays and were performed in the same microplate where error bars represent SEM of 4 technical replicates. Statistical
significance was determined using a one-way ANOVA with a Tukey’s post-test (***P < 0.001).
The most interesting aspect of the MS-based assay however, was
that it was able to further separate the products of destabilization,
determining the existence and relative abundance, of several
conformational states. Previously published thermal stability data
has not detected these states (Furukawa and O’Halloran, 2005;
Rodriguez et al., 2005), most likely due to the low resolution
provided by the technique, or that these conformations are in a
constant state of flux. Higher resolution analyses of disordered
SOD1 have been conducted using NMR, where reduced apo-
SOD1G93A was found to be highly unstructured, with little
propensity to form secondary structure (Luchinat et al., 2014),
and reduced apo-SOD1WT was found to assume a monomeric
native-like β-barrel structure with disordered loops (Sekhar et al.,
2015). This model of reduced apo-SOD1WT matches the analysis
presented here where the relatively low charge state distribution
is indicative of a more compact monomeric species, close to what
we observed for disulfide oxidized holo-SOD1WT.
Likewise, other work has considered reduced apo-SOD1G93A
to be representative of several other SOD1 variants, including
SOD1G37R, which is in partial agreement with our results
(Luchinat et al., 2014). SOD1G37R was the most destabilized
variant observed, with SOD1G93A a close second. In-cell NMR
spectroscopy revealed that the levels of unstructured reduced
apo-SOD1G37R and reduced apo-SOD1G93A were similar when
overexpressed in mammalian cells, failing to detect any tertiary
structure (Luchinat et al., 2014). In contrast, the MS-based assay
performed here detected reduced apo-SOD1 species inhabiting
quaternary, tertiary, and unstructured states, as determined
by IM-MS, across all of our SOD1 variants. The discrepancy
is potentially due to the experimental design, i.e., the work
present here has investigated SOD1 that has been unfolded from
its native conformation, whereas Luchinat et al. (2014) and
colleagues have investigated SOD1 structures that may not yet be
folded. Regardless of the order, the removal of post-translational
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modifications from SOD1 is widely thought to result in a product
that is similar to the immature polypeptide that can take part in
aggregation.
The isolated protein and cell-based aggregation assays showed
a clear difference between specific SOD1 variant aggregation
propensities. For the most part, aggregation in the cellular
context correlated with aggregation of isolated protein, with
the exception of SOD1G37R. Ivanova et al. (2014) determined
that the SOD1 sequence segment 30KVWGSIKGL38 was a fibril
forming segment but the same peptide containing the SOD1G37R
mutation did not form fibrillar structures, suggesting that the
SOD1G37R mutation may lead to aggregation through other fibril
forming segments or to amorphous aggregation. SOD1G37R was
a consistent outlier throughout this work, and even more so
when taking into account the interesting correlation between
patient survival time and SOD1 mutation, where in general
SOD1 variants more prone to aggregation are correlated with
a more rapid disease progression (Wang et al., 2008). Given
the association with a long disease course, one might expect
SOD1G37R to have a low aggregation propensity in cells, as well as
a low isolated protein aggregation propensity. However, its in-cell
aggregation was significantly increased compared to SOD1WT,
similar to that observed for SOD1G93A and SOD1V148G. A
potential explanation for this is the difference between the
intracellular environment compared to that of an isolated
protein assay. The isolated protein assay contains only pure
SOD1 protein at a relatively low concentration (uncrowded)
of 30 µM dimer, and is optimized to produce fibrillar
aggregates at a rapid rate with vigorous shaking. The cytoplasm
contains an abundance of protein and other macromolecules
in high concentration (∼400mg/mL), resulting in a crowded
environment (Fulton, 1982; Zeskind et al., 2007). This crowding
effect, along with other cellular processes, are likely changing
the dynamics of SOD1 aggregation, when compared to isolated
protein. Indeed, transfection of cells typically results in variable
expression levels of the protein of interest, across the population
of cells that have taken up the vector. In the case presented here,
the highest expressing cells are the ones most likely to develop
inclusions, consistent with the idea that protein concentration
is an important factor contributing to aggregation. Inducing
high expression levels of SOD1 in the absence of similarly high
expression of the copper-chaperone for SOD1 (CCS) is likely
to result in a large pool of reduced apo-SOD1 that is more
susceptible to aggregation. Recent work has highlighted a faulty
interaction between SOD1A4V and human CCS (Wright et al.,
2016). This suggests that SOD1 aggregation may result from
an overloading of its specific quality control systems in motor
neurons. Another explanation is the energy driven aggregation
that occurs in cells. Previous work has shown that large inclusions
(similar to the inclusions we examine here) are dependent upon
microtubule transport (Farrawell et al., 2015) and are not a
simply a product of random aggregation. It is possible that
aggregation occurs after misfolded SOD1 has been transported
and concentrated at the site of an inclusion.
The analytical SEC and MS analysis lends credence to the
concept of crowding, where destabilized SOD1 was concentrated
prior to SEC (∼450µM), however, the presence of a substantial
amount of high molecular weight species was observed only
in the case of SOD1G37R, indicating a rapid formation of
oligomeric species for this variant. These oligomeric species
were sensitive to dilution, as evidenced by the most abundant
species in our MS analysis of the SOD1G37R void volume being
monomeric. This potentially translates into a greater cellular
aggregation propensity due to the high concentration of SOD1
with certain cells, but a lower propensity of isolated protein
to aggregate due to the comparatively decreased concentration
of SOD1 in our assay. Furthermore, there is a possibility that
SOD1G37R forms aggregate nuclei rapidly, leading to a decreased
pool of available monomer to template onto extending fibrils,
although we cannot rule out the possibility of a competing
amorphous aggregation pathway for SOD1G37R. Interestingly,
while in many neurodegenerative diseases soluble hydrophobic
oligomeric aggregates are implicated as the most toxic aggregate
species (Bolognesi et al., 2010), here we find the opposite;
SOD1G37R has the highest propensity to form oligomers, but is
the amongst the slowest progressing mutants in humans.
Recent work has emphasized the role that different
aggregation pathways, leading to the formation of different
aggregate strains, may play in the role of amyotrophic lateral
sclerosis (Bergh et al., 2015; Lang et al., 2015; Bidhendi et al.,
2016). Using binary epitope mapping, Bergh et al. (2015)
determined that mice overexpressing human SOD1D90A
developed SOD1 aggregates that were found to be competing
strains termed strain A and B. Each strain demonstrated
differential kinetics and mortality in mice. A follow on from
this saw the injection of mice expressing human SOD1WT
with either of these strains developing ALS-like symptom at
different rates, and also presented different pathophysiology
(Bidhendi et al., 2016). The strain hypothesis may explain,
at least in part, why different SOD1 mutants present variable
disease progression in patients. Indeed, the work presented
here indicates that SOD1G37R may be aggregating into a
strain distinct from SOD1G93A similar to previous work that
suggested SOD1G37R mice spinal cord homogenates could not
transmit disease to a SOD1G85R mouse, but that SOD1G93A
mice homogenates could transmit disease (Ayers et al., 2014).
Given the MS data showed that SOD1G37R had the highest
abundance of unfolded monomer, it might be predicted to
have substantially altered aggregation dynamics in the presence
of preformed aggregate seed (decreased lag phase, increased
elongation rate), however this was not the case. Previous work
has shown that the SOD1 sequence segment 30KVWGSIKGL38
is fibril forming (Ivanova et al., 2014), and in conjunction with
our observations presented here suggests it is possible that
SOD1G93A fibrils are polymerizing based on this segment, and
therefore the seeded aggregation of SOD1G37R did not take place
due to the arginine substitution at position 37. This combined
with the observation of high levels of unfolded SOD1G37R in
the cell-free assays would infer SOD1G37R fibril formation is
dependent upon other sequence segments, however, we still
observe a low in vitro aggregation propensity for this SOD1
variant, indicating that the sequence segment 30KVWGSIKGL38
may indeed be the primary fibril forming segment within SOD1.
This SOD1G37R aggregate strain may be, for the most part,
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FIGURE 9 | Correlation of measured variables to human disease
duration. Since sufferers of SOD1-associated fALS cases have variable
survival times post-diagnosis, the measured variables in this work were plotted
against mean disease duration. (A) The relative maximum ThT signal from in
vitro aggregation assay plotted against disease duration gave a plausible
correlation (r2 = 0.77). (B) The percentage of cells containing inclusions 48 h
post-transfection plotted against disease duration gave a very weak
correlation (r2 = 0.16). (C) Plotting the cell death comparative to SOD1WT
48 h post-transfection gave a very weak correlation (r2 = 0.01). (D) Plotting
the relative abundance of unfolded SOD1 measured from MS assays against
disease duration gave a very weak correlation (r2 = 0.03).
benign, explaining the comparatively long disease duration
of this SOD1 variant, although further characterization of
in vitro and in vivo SOD1G37R aggregates would need to be
performed to confirm this interpretation. Interestingly, of
the variables measured here, including in vitro aggregation,
cellular aggregation, structural destabilization, and cell death, the
strongest correlation to human SOD1-associated fALS patient
survival was in vitro aggregation (Figure 9A). Cellular inclusion
formation, cell death, and structural destabilization all had very
weak correlations with patient survival (Figures 9B,C,D) again
consistent with the idea that a strain of aggregate reactive with
ThT might best predict disease severity.
In conclusion, the work presented here underscores the
necessity of combining mass analysis techniques to size
determination techniques, as the relationship between size and
mass may be drastically altered by conformational changes
to molecules. Native mass spectrometry is an excellent
technique as it provides a means by which to not only
separate different conformers, but identify modification
states, as we have shown above. The conformers we have
identified related to different monomeric conformational
states of several ALS-associated SOD1 variants, showing
that disulfide reduction and metal chelation resulted in
differential conformational states, which correlates with cellular
aggregation and toxicity. SOD1G37R presented itself as an outlier
when taking into account its high abundance of unfolded
protein and oligomeric species, yet a comparatively low in
vitro aggregation propensity. Seeding SOD1G37R aggregation
with preformed SOD1G93A aggregates had no effect on its
aggregation kinetics, suggesting that SOD1G37R may aggregate
as a different strain and thus potentially explain its slow
disease progression. Understanding the interplay between
unfolding and subsequent aggregation, as well as the potential
for the formation of variable aggregate strains of more SOD1
variants may shed light on the phenomenon of SOD1 variant
related differential patient survival times, and may also provide
information on the disease causing species in SOD1-associated
ALS.
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